# YORVIPATH
> **NDA216490** · New Drug Application · Sponsor: ASCENDIS PHARMA BONE · Approved 2024-08-09
## Drug
- **FDA Application Number:** NDA216490
- **Application type:** New Drug Application
- **Brand name:** YORVIPATH
- **Generic name:** PALOPEGTERIPARATIDE
- **Active ingredients:** PALOPEGTERIPARATIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ASCENDIS PHARMA BONE
- **Manufacturer:** Ascendis Pharma, Endocrinology, Inc.
- **First approval:** 2024-08-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216490)
---
*AI Analytics · CC0 1.0*